Literature DB >> 12524433

The recycling of apolipoprotein E in primary cultures of mouse hepatocytes. Evidence for a physiologic connection to high density lipoprotein metabolism.

Monica H Farkas1, Larry L Swift, Alyssa H Hasty, MacRae F Linton, Sergio Fazio.   

Abstract

Internalization of apoE-containing very low density protein (VLDL) by hepatocytes in vivo and in vitro leads to apoE recycling and resecretion. Because of the role of apoE in VLDL metabolism, apoE recycling may influence lipoprotein assembly or remnant uptake. However, apoE is also a HDL protein, and apoE recycling may be related to reverse cholesterol transport. To investigate apoE recycling, apoE(-/-) mouse hepatocytes were incubated (pulsed) with wild-type mouse lipoproteins, and cells and media were collected at chase periods up to 24 h. When cells were pulsed with VLDL, apoE was resecreted within 30 min. Although the mass of apoE in the media decreased with time, it could be detected up to 24 h after the pulse. Intact intracellular apoE was also detectable 24 h after the pulse. ApoE was also resecreted when cells were pulsed with HDL. When apoA-I was included in the chase media after a pulse with VLDL, apoE resecretion increased 4-fold. Furthermore, human apoE was resecreted from wild-type mouse hepatocytes after a pulse with human VLDL. Finally, apoE was resecreted from mouse peritoneal macrophages after pulsing with VLDL. We conclude that 1) HDL apoE recycles in a quantitatively comparable fashion to VLDL apoE; 2) apoE recycling can be modulated by extracellular apoA-I but is not affected by endogenous apoE; and 3) recycling occurs in macrophages as well as in hepatocytes, suggesting that the process is not cell-specific.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524433     DOI: 10.1074/jbc.M208026200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia.

Authors:  Jianjia Fan; Sophie Stukas; Charmaine Wong; Jennifer Chan; Sharon May; Nicole DeValle; Veronica Hirsch-Reinshagen; Anna Wilkinson; Michael N Oda; Cheryl L Wellington
Journal:  J Lipid Res       Date:  2011-06-26       Impact factor: 5.922

2.  Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Authors:  Hagai Tavori; Ilaria Giunzioni; Irene M Predazzi; Deanna Plubell; Anna Shivinsky; Joshua Miles; Rachel M Devay; Hong Liang; Shirya Rashid; MacRae F Linton; Sergio Fazio
Journal:  Cardiovasc Res       Date:  2016-03-15       Impact factor: 10.787

3.  Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.

Authors:  Herman J Kempen; Monica Gomaraschi; S Eralp Bellibas; Stephanie Plassmann; Brad Zerler; Heidi L Collins; Steven J Adelman; Laura Calabresi; Peter L J Wijngaard
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

Review 4.  PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9.

Authors:  Hagai Tavori; Ilaria Giunzioni; Sergio Fazio
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-04       Impact factor: 3.243

Review 5.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

6.  Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.

Authors:  Michael Altenburg; Jose Arbones-Mainar; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-27       Impact factor: 8.311

7.  Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.

Authors:  Lance A Johnson; Michael K Altenburg; Rosemary L Walzem; Lori T Scanga; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

8.  Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).

Authors:  Geeta Datta; C Roger White; Nassrin Dashti; Manjula Chaddha; Mayakonda N Palgunachari; Himanshu Gupta; Shaila P Handattu; David W Garber; G M Anantharamaiah
Journal:  Atherosclerosis       Date:  2009-07-15       Impact factor: 5.162

9.  Self-association of human PCSK9 correlates with its LDLR-degrading activity.

Authors:  Daping Fan; Patricia G Yancey; Shenfeng Qiu; Lei Ding; Edwin J Weeber; MacRae F Linton; Sergio Fazio
Journal:  Biochemistry       Date:  2008-01-16       Impact factor: 3.162

10.  Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.

Authors:  Hagai Tavori; Daping Fan; John L Blakemore; Patricia G Yancey; Lei Ding; Macrae F Linton; Sergio Fazio
Journal:  Circulation       Date:  2013-05-20       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.